201
Participants
Start Date
June 28, 2017
Primary Completion Date
July 8, 2020
Study Completion Date
April 6, 2021
VGX-3100
1 mL VGX-3100 will be injected IM and delivered by EP using CELLECTRA™-5PSP on Day 0, Week 4 and Week 12.
Placebo
1 mL of Placebo will be injected IM and delivered by EP using CELLECTRA™-5PSP on Day 0, Week 4 and Week 12.
Electroporation (EP)
Intramuscular injection followed by EP with the CELLECTRA™ 5PSP device.
Lynette Reynders Private Practice, Centurion
Kätilöopiston sairaala, Helsinki
Ziekenhuis Oost-Limburg, Genk
Perpetual Succour Hospital, Cebu
Centre Hospitalier Universitaire Ambroise Paré, Mons
University of Cape Town, Cape Town
Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat
Columbia University Medical Center, New York
East Tallinn Central Hospital Womens Clinic, Tallinn
Chulalongkorn University, Bangkok
Siriraj Hospital Mahidol University, Bangkok
Suffolk Obstetrics and Gynecology, Port Jefferson
Unidad de Ensayos Clinicos (UNIDEC) del Policlinico Universidad Nacional Mayor de San Marcos, Lima
Liga Peruana De Lucha Contra El Cancer, Lima
Istituto Nazionale Dei Tumori, Milan
Istituto Europeo Di Oncologia, Milan
Universitätsklinikum Hamburg Eppendorf, Hamburg
Group For Women, Norfolk
Eastern Virginia Medical School, Norfolk
Lyndhurst Clinical Research, Winston-Salem
Hospital Clinico San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Magnolia Ob/Gyn Research Center, LLC, Myrtle Beach
Greenville Pharmaceutical Research, Inc., Greenville
Augusta University, Augusta
Comprehensive Clinical Trials LLC, West Palm Beach
Altus Research, Lake Worth
Salom and Tangir LLC, Miramar
Women's Medical Research Group, Clearwater
Chattanooga Medical Research Inc, Chattanooga
Women's Physician Group, Memphis
Nuevo Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalajara
Elisabeth Krankenhaus Essen GmbH, Essen
Saginaw Valley Medical Research Group LLC, Saginaw
Tartu University Hospital, Tartu
Meridian Clinical Research Norfolk, Norfolk
Praetorian Pharmaceutical Research, LLC, Marrero
UAG Innovation Women Research, LLC, Houston
Mesa Obstetricians and Gynecologist, Mesa
Women's Health Research, Scottsdale
Visions Clinical Research-Tucson, Tucson
New Jersey Medical School, Newark
Instituto de Ginecología, Rosario
Hospital Italiano de Buenos Aires, Buenos Aires
DIM Clínica Privada, Ramos Mejía
Pärnu Hospital, Pärnu
Lääkäriasema Cantti Oy, Kuopio
Fondazione Policlinico Universitario A Gemelli, Rome
Vilnius University Hospital Santaros Klinikos, Vilnius
Vilnius District Central Outpatient Clinic, Vilnius
Niepubliczny Zakład Opieki Zdrowotnej Profimed, Lublin
Samodzielny Publiczny Szpital Kliniczny nr 1 w Lublinie, Lublin
Centrum Medyczne Angelius Provita, Katowice
Centro Hospitalar E Universitário de Coimbra EPE, Coimbra
Centro Hospitalar de Lisboa Norte, EPE - Hospital de Santa Maria, Lisbon
Puerto Rico Translational Research Center (PRTRC), Rio Piedras
MCM GYNPED, s.r.o., Dubnica nad Váhom
Univerzitna nemocnica Martin, Martin
Aberdeen Royal Infirmary - PPDS, Aberdeen
St Marys Hospital, London
Lead Sponsor
Inovio Pharmaceuticals
INDUSTRY